News
8h
Zacks Investment Research on MSNUnited Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?Wall Street expects a year-over-year increase in earnings on higher revenues when United Therapeutics (UTHR) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...
1d
Fintel on MSNB of A Securities Upgrades United Therapeutics (UTHR)Fintel reports that on April 21, 2025, B of A Securities upgraded their outlook for United Therapeutics (NasdaqGS:UTHR) from ...
As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...
BofA upgraded United Therapeutics (UTHR) to Neutral from Underperform with a $314 price target Stay Ahead of the Market: Discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results